ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.93
-0.04 (-0.40%)
At close: Dec 5, 2025, 4:00 PM EST
9.62
-0.31 (-3.12%)
After-hours: Dec 5, 2025, 5:01 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $981.57 million as of December 5, 2025. Its market cap has decreased by -26.71% in one year.
Market Cap
981.57M
Enterprise Value
863.16M
1-Year Change
-26.71%
Ranking
Category
Stock Price
$9.93
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $981.57M, an increase of 72.74%. That is a compound annual growth rate of 19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 985.52M | -3.88% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 906.62B |
| Johnson & Johnson | 486.08B |
| AbbVie | 402.49B |
| UnitedHealth Group | 301.61B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 249.94B |
| Abbott Laboratories | 217.22B |